This was further substantiated by their observation that XLCNM patient fibroblasts also overexpressed DNM2 at the protein level [19, 78], suggesting that elevated DNM2 levels may act as a pathogenic contributor in XLCNM. The gene discussed is DNM2; the disease is X-linked myotubular myopathy.